NaviFUS Corp. (6872.TWO)

TWD 25.65

(9.85%)

Total Assets Summary of NaviFUS Corp.

  • NaviFUS Corp.'s latest annual total assets in 2023 was 490.53 Million TWD , down -6.4% from previous year.
  • NaviFUS Corp.'s latest quarterly total assets in 2024 Q2 was 610.9 Million TWD , down -3.8% from previous quarter.
  • NaviFUS Corp. reported annual total assets of 524.06 Million TWD in 2022, down -11.16% from previous year.
  • NaviFUS Corp. reported annual total assets of 589.91 Million TWD in 2021, up 67.56% from previous year.
  • NaviFUS Corp. reported quarterly total assets of 610.9 Million TWD for 2024 Q2, down -3.8% from previous quarter.
  • NaviFUS Corp. reported quarterly total assets of 490.53 Million TWD for 2023 FY, down -6.4% from previous quarter.

Annual Total Assets Chart of NaviFUS Corp. (2023 - 2019)

Historical Annual Total Assets of NaviFUS Corp. (2023 - 2019)

Year Total Assets Total Assets Growth
2023 490.53 Million TWD -6.4%
2022 524.06 Million TWD -11.16%
2021 589.91 Million TWD 67.56%
2020 352.05 Million TWD 0.0%
2019 - TWD 0.0%

Peer Total Assets Comparison of NaviFUS Corp.

Name Total Assets Total Assets Difference
SYN-TECH Chem. & Pharm. Co., Ltd. 2.9 Billion TWD 83.09%
Level Biotechnology Inc. 822.67 Million TWD 40.373%
Sagittarius Life Science Corp 664.72 Million TWD 26.205%
NeoCore Technology Co., Ltd. 548.74 Million TWD 10.608%
TaiMed Biologics Inc. 3.89 Billion TWD 87.403%
GlycoNex Incorporation 1.55 Billion TWD 68.41%
VBI 452.1 Million TWD -8.501%
GeneReach Biotechnology Corp. 1.17 Billion TWD 58.293%
Taiwan Advance Bio-Pharmaceutical Inc. 748.57 Million TWD 34.47%
Visgeneer Inc. 397.17 Million TWD -23.506%
Mycenax Biotech Inc. 3.77 Billion TWD 86.99%
Sunmax Biotechnology Co., Ltd. 2.15 Billion TWD 77.28%
G&E Herbal Biotechnology Co., Ltd. 883.09 Million TWD 44.453%
Medigen Vaccine Biologics Corporation 6.09 Billion TWD 91.949%
TaiwanJ Pharmaceuticals Co., Ltd. 73.55 Million TWD -566.868%
Enimmune corporation 604.82 Million TWD 18.897%
TaiRx, Inc. 833.74 Million TWD 41.165%
CHO Pharma, Inc. 3.08 Billion TWD 84.105%
EirGenix Inc. 11.16 Billion TWD 95.606%
BioLASCO Taiwan Co., Ltd. 573.13 Million TWD 14.413%
Sunny Pharmtech Inc. 1.71 Billion TWD 71.353%
Lin BioScience, Inc. 3.59 Billion TWD 86.362%
BioGend Therapeutics Co., Ltd. 1.05 Billion TWD 53.304%
Feng Chi Biotech Corp. 301.03 Million TWD -62.951%
Bio Preventive Medicine Corp. 264.65 Million TWD -85.347%
Lukas Biomedical Inc. 441.19 Million TWD -11.184%
RBC Bioscience Corporation 753.79 Million TWD 34.924%
BiOptic Inc. 613.77 Million TWD 20.079%
BRIM Biotechnology, Inc. 1.77 Billion TWD 72.421%
Shine-On BioMedical Co.,Ltd. 1.15 Billion TWD 57.702%
Great Novel Therapeutics Biotech & Medicals 644.84 Million TWD 23.93%
Syngen Biotech Co.,Ltd. 3.1 Billion TWD 84.208%
Anti-Microbial Savior BioteQ Co., Ltd 128.04 Million TWD -283.09%
SynCore Biotechnology Co.,Ltd 378.36 Million TWD -29.647%
Genomics BioSci & Tech. Co.,Ltd. 1.13 Billion TWD 56.737%
Neith Corporation 192.15 Million TWD -155.284%
Advagene Biopharma Co., Ltd. 147.93 Million TWD -231.59%
Gwo Xi Stem Cell Applied Technology Co. , Ltd 1.22 Billion TWD 59.98%
Sinew Pharma Inc. 1.36 Billion TWD 64.021%
Andros Pharmaceuticals Co.,Ltd 529.14 Million TWD 7.297%
Greenyn Biotechnology Co., Ltd 1.16 Billion TWD 57.763%
Lumosa Therapeutics Co., Ltd. 1.65 Billion TWD 70.383%
AP Biosciences Inc 890.75 Million TWD 44.93%
Medigen Biotechnology Corp. 8.52 Billion TWD 94.247%
3D Global Biotech Inc. 324.14 Million TWD -51.331%
Pharmosa Biopharm Inc. 1.33 Billion TWD 63.218%
Intech Biopharm Corporation 2.71 Billion TWD 81.906%
Oneness Biotech Co., Ltd. 15.36 Billion TWD 96.807%
Eusol Biotech Co.,Ltd. 410.25 Million TWD -19.567%
TWi Biotechnology, Inc. 396.85 Million TWD -23.607%
Ever Supreme Bio Technology Co., Ltd 2.07 Billion TWD 76.37%
TCI GENE Inc. 1.16 Billion TWD 57.928%
MegaPro Biomedical Co., Ltd 294.58 Million TWD -66.52%
Senhwa Biosciences, Inc. 1.36 Billion TWD 64.019%
Taiwan Bio Therapeutics Co., Ltd 941.76 Million TWD 47.913%
NatureWise Biotech & Medicals Corporation 698.45 Million TWD 29.768%
PharmaEngine, Inc. 3.95 Billion TWD 87.594%
Savior Lifetec Corporation 3.82 Billion TWD 87.168%
TaiGen Biopharmaceuticals Holdings Limited 1.22 Billion TWD 60.114%
OBI Pharma, Inc. 5.6 Billion TWD 91.247%
Meribank Biotech Co., Ltd 1.06 Billion TWD 53.811%
Acepodia, Inc. 6.81 Billion TWD 92.806%
Caliway Biopharmaceuticals Co., Ltd. 3.82 Billion TWD 87.181%